tiprankstipranks
Advertisement
Advertisement

RaySearch AGM Approves Dividend, LTI 2026 and Share Buyback Mandate

Story Highlights
  • RaySearch’s AGM re-elected its board, confirmed Deloitte as auditor, and approved executive pay guidelines and board fees.
  • Shareholders approved a SEK 4 dividend, a new LTI 2026 share-based plan, and authority for Class B share buybacks to optimize capital structure.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
RaySearch AGM Approves Dividend, LTI 2026 and Share Buyback Mandate

Meet Samuel – Your Personal Investing Prophet

RaySearch Laboratories AB ( ($SE:RAY.B) ) has issued an announcement.

RaySearch Laboratories’ 2026 Annual General Meeting in Stockholm re-elected board members Carl Filip Bergendal, Johan Löf, Britta Wallgren and Hans Wigzell, with Wigzell continuing as chairman, and approved Deloitte as auditor for another term. Shareholders also adopted the 2025 remuneration report, approved updated guidelines for executive pay, and set board fees at SEK 840,000 for the chair and SEK 300,000 for other non-executive directors.

The AGM approved a dividend of SEK 4 per share, with remaining profits of about SEK 238.3 million carried forward, underscoring a continued commitment to shareholder returns. Investors further backed a new performance-based long-term incentive program (LTI 2026) and authorized the board to repurchase and transfer Class B shares both to meet obligations under the incentive plan and to adjust the company’s capital structure to support shareholder value.

More about RaySearch Laboratories AB

RaySearch Laboratories AB is a Swedish medical technology company specializing in software for advanced cancer treatment. Its portfolio includes the RayStation treatment planning system, the RayCare oncology information system, and newer products such as the RayIntelligence analytics platform and RayCommand treatment control system, used by more than 1,200 clinics in 51 countries and listed on Nasdaq Stockholm since 2003.

Founded in 2000 as a spin-off from the Karolinska Institute, RaySearch focuses on linking treatment machines with planning and information systems to improve clinical workflows. Several of its products remain subject to regulatory clearance in certain markets, underscoring its position in highly regulated global healthcare technology.

Average Trading Volume: 203,468

Technical Sentiment Signal: Hold

Current Market Cap: SEK6.59B

Find detailed analytics on RAY.B stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1